DOPRAM

This brand name is authorized in France, Japan, Malta, Netherlands, Romania, United Kingdom, United States

Active ingredients

The drug DOPRAM contains one active pharmaceutical ingredient (API):

1 Doxapram UNII P5RU6UOQ5Y - DOXAPRAM HYDROCHLORIDE

Doxapram is an analeptic agent (a stimulant of the central nervous system). Doxapram produces respiratory stimulation mediated through the peripheral carotid chemoreceptors. It is thought to stimulate the carotid body by inhibiting certain potassium channels. Used as temporary measure in hospitalized patients with acute respiratory insufficiency superimposed on chronic obstructive pulmonary disease. Read about Doxapram

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DOPRAM Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/Old
DOPRAM Sterile solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R07AB01	Doxapram	R Respiratory system → R07 Other respiratory system products → R07A Other respiratory system products → R07AB Respiratory stimulants
Discover more medicines within R07AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 68296666
Country: JP	医薬品医療機器総合機構	Identifier(s): 2219400A1031
Country: MT	Medicines Authority	Identifier(s): AA1411/02501, AA565/32502
Country: NL	Z-Index G-Standaard	Identifier(s): 13651471
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 202061
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69245001
Country: US	FDA, National Drug Code	Identifier(s): 0641-6018